These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Engagement of activin and bone morphogenetic protein signaling pathway Smad proteins in the induction of inhibin B production in ovarian granulosa cells. Bondestam J; Kaivo-oja N; Kallio J; Groome N; Hydén-Granskog C; Fujii M; Moustakas A; Jalanko A; ten Dijke P; Ritvos O Mol Cell Endocrinol; 2002 Sep; 195(1-2):79-88. PubMed ID: 12354674 [TBL] [Abstract][Full Text] [Related]
23. Is the action of inhibin mediated via a unique receptor? Robertson DM; Hertan R; Farnworth PG Rev Reprod; 2000 Sep; 5(3):131-5. PubMed ID: 11006162 [TBL] [Abstract][Full Text] [Related]
24. The contribution of inhibins and activins to malignant prostate disease. Risbridger GP; Mellor SL; McPherson SJ; Schmitt JF Mol Cell Endocrinol; 2001 Jun; 180(1-2):149-53. PubMed ID: 11451585 [TBL] [Abstract][Full Text] [Related]
25. Regulation of osteoblastogenesis and osteoclastogenesis by the other reproductive hormones, Activin and Inhibin. Nicks KM; Perrien DS; Akel NS; Suva LJ; Gaddy D Mol Cell Endocrinol; 2009 Oct; 310(1-2):11-20. PubMed ID: 19615428 [TBL] [Abstract][Full Text] [Related]
26. Activins in reproductive biology and beyond. Wijayarathna R; de Kretser DM Hum Reprod Update; 2016 Apr; 22(3):342-57. PubMed ID: 26884470 [TBL] [Abstract][Full Text] [Related]
27. An activin/furin regulatory loop modulates the processing and secretion of inhibin alpha- and betaB-subunit dimers in pituitary gonadotrope cells. Antenos M; Zhu J; Jetly NM; Woodruff TK J Biol Chem; 2008 Nov; 283(48):33059-68. PubMed ID: 18826955 [TBL] [Abstract][Full Text] [Related]
28. Is sotatercept, which traps activins and growth differentiation factors, a new dawn in treating pulmonary arterial hypertension (PAH)? Doggrell SA Expert Opin Biol Ther; 2023; 23(7):589-593. PubMed ID: 37269300 [TBL] [Abstract][Full Text] [Related]
29. The role of inhibins and activins in prostate cancer pathogenesis. Dowling CR; Risbridger GP Endocr Relat Cancer; 2000 Dec; 7(4):243-56. PubMed ID: 11174846 [TBL] [Abstract][Full Text] [Related]
30. Altered bone morphogenetic protein and transforming growth factor-beta signaling in rat models of pulmonary hypertension: potential for activin receptor-like kinase-5 inhibition in prevention and progression of disease. Long L; Crosby A; Yang X; Southwood M; Upton PD; Kim DK; Morrell NW Circulation; 2009 Feb; 119(4):566-76. PubMed ID: 19153267 [TBL] [Abstract][Full Text] [Related]
31. Activin-related proteins in bovine mammary gland: localization and differential expression during gestational development and differentiation. Bloise E; Cassali GD; Ferreira MC; Ciarmela P; Petraglia F; Reis FM J Dairy Sci; 2010 Oct; 93(10):4592-601. PubMed ID: 20854993 [TBL] [Abstract][Full Text] [Related]
32. Inhibins are the major activin ligands expressed during early thymocyte development. Licona P; Chimal-Monroy J; Soldevila G Dev Dyn; 2006 Apr; 235(4):1124-32. PubMed ID: 16477644 [TBL] [Abstract][Full Text] [Related]
33. An emerging class of new therapeutics targeting TGF, Activin, and BMP ligands in pulmonary arterial hypertension. Upton PD; Dunmore BJ; Li W; Morrell NW Dev Dyn; 2023 Mar; 252(3):327-342. PubMed ID: 35434863 [TBL] [Abstract][Full Text] [Related]
34. Quantitative Differences in TGF-β Family Members Measured in Small Antral Follicle Fluids From Women With or Without PCO. Kristensen SG; Kumar A; Kalra B; Pors SE; Bøtkjær JA; Mamsen LS; Colmorn LB; Fedder J; Ernst E; Owens LA; Hardy K; Franks S; Andersen CY J Clin Endocrinol Metab; 2019 Dec; 104(12):6371-6384. PubMed ID: 31287539 [TBL] [Abstract][Full Text] [Related]
35. Transforming growth factor-beta modulates inhibin A bioactivity in the LbetaT2 gonadotrope cell line by competing for binding to betaglycan. Ethier JF; Farnworth PG; Findlay JK; Ooi GT Mol Endocrinol; 2002 Dec; 16(12):2754-63. PubMed ID: 12456797 [TBL] [Abstract][Full Text] [Related]
36. Sotatercept for Pulmonary Arterial Hypertension in the Inpatient Setting. Torbic H; Tonelli AR J Cardiovasc Pharmacol Ther; 2024; 29():10742484231225310. PubMed ID: 38361351 [TBL] [Abstract][Full Text] [Related]
37. Immunolocalization of inhibin/activin subunit proteins during the breeding season in testes and scented glands of muskrats (Ondatra zibethicus). Ma X; Zhang H; Weng J; Sheng X; Lu L; Hu X; Liu S; Xu M; Weng Q; Watanabe G; Taya K J Vet Med Sci; 2011 Sep; 73(9):1199-205. PubMed ID: 21532261 [TBL] [Abstract][Full Text] [Related]
38. Activins and inhibins in mammalian testis development: new models, new insights. Barakat B; Itman C; Mendis SH; Loveland KL Mol Cell Endocrinol; 2012 Aug; 359(1-2):66-77. PubMed ID: 22406273 [TBL] [Abstract][Full Text] [Related]
39. Activin and inhibin have antagonistic effects on ligand-dependent heteromerization of the type I and type II activin receptors and human erythroid differentiation. Lebrun JJ; Vale WW Mol Cell Biol; 1997 Mar; 17(3):1682-91. PubMed ID: 9032295 [TBL] [Abstract][Full Text] [Related]
40. Activin signaling through activin receptor type II causes the cachexia-like symptoms in inhibin-deficient mice. Coerver KA; Woodruff TK; Finegold MJ; Mather J; Bradley A; Matzuk MM Mol Endocrinol; 1996 May; 10(5):534-43. PubMed ID: 8732684 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]